148 related articles for article (PubMed ID: 31995775)
1. Assessing potential mechanisms of arsenic-induced skin lesions and cancers: Human and in vitro evidence.
Zeng Q; Zhang A
Environ Pollut; 2020 May; 260():113919. PubMed ID: 31995775
[TBL] [Abstract][Full Text] [Related]
2. Assessing the potential value and mechanism of
Zeng Q; Wei S; Sun B; Zhang A
Hum Exp Toxicol; 2021 Dec; 40(12):2113-2122. PubMed ID: 34085585
[TBL] [Abstract][Full Text] [Related]
3. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
4. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.
Yu S; Liao WT; Lee CH; Chai CY; Yu CL; Yu HS
J Dermatol; 2018 Nov; 45(11):1271-1277. PubMed ID: 30144155
[TBL] [Abstract][Full Text] [Related]
5. miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions.
Al-Eryani L; Jenkins SF; States VA; Pan J; Malone JC; Rai SN; Galandiuk S; Giri AK; States JC
PLoS One; 2018; 13(8):e0202579. PubMed ID: 30114287
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-related Bowen's disease, palmar keratosis, and skin cancer.
Cöl M; Cöl C; Soran A; Sayli BS; Oztürk S
Environ Health Perspect; 1999 Aug; 107(8):687-9. PubMed ID: 10417369
[TBL] [Abstract][Full Text] [Related]
7. Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
Hsu LI; Chen GS; Lee CH; Yang TY; Chen YH; Wang YH; Hsueh YM; Chiou HY; Wu MM; Chen CJ
Am J Epidemiol; 2013 Feb; 177(3):202-12. PubMed ID: 23299695
[TBL] [Abstract][Full Text] [Related]
8. miRNA-182-5p, via HIF2α, contributes to arsenic carcinogenesis: evidence from human renal epithelial cells.
Fang X; Sun R; Hu Y; Wang H; Guo Y; Yang B; Pi J; Xu Y
Metallomics; 2018 Nov; 10(11):1607-1617. PubMed ID: 30334557
[TBL] [Abstract][Full Text] [Related]
9. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
[TBL] [Abstract][Full Text] [Related]
10. Arsenic-Induced Carcinogenesis and Immune Dysregulation.
Huang HW; Lee CH; Yu HS
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31374811
[TBL] [Abstract][Full Text] [Related]
11. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
13. Role of N6-methyladenosine RNA modification in the imbalanced inflammatory homeostasis of arsenic-induced skin lesions.
Yang F; Zhang A
Environ Toxicol; 2022 Aug; 37(8):1831-1839. PubMed ID: 35363433
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of chronic arsenicism: review of seventeen cases.
Wong SS; Tan KC; Goh CL
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):179-85. PubMed ID: 9486671
[TBL] [Abstract][Full Text] [Related]
15. miR-191 is involved in renal dysfunction in arsenic-exposed populations by regulating inflammatory response caused by arsenic from burning arsenic-contaminated coal.
Xu Y; Zou Z; Liu Y; Wang Q; Sun B; Zeng Q; Liu Q; Zhang A
Hum Exp Toxicol; 2020 Jan; 39(1):37-46. PubMed ID: 31775542
[TBL] [Abstract][Full Text] [Related]
16. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.
Yu HS; Chang KL; Wang CM; Yu CL
J Dermatol; 1992 Nov; 19(11):710-4. PubMed ID: 1293158
[TBL] [Abstract][Full Text] [Related]
17. [Bowen's disease with multiple lesions caused by chronic arsenic poisoning].
Giménez H; Agurruza JM; Martínez G; Grasa MP; Carapeto FJ
Actas Dermosifiliogr; 1980; 71(9-10):337-42. PubMed ID: 7223522
[No Abstract] [Full Text] [Related]
18. SILAC-based quantitative proteomic analysis reveals widespread molecular alterations in human skin keratinocytes upon chronic arsenic exposure.
Mir SA; Pinto SM; Paul S; Raja R; Nanjappa V; Syed N; Advani J; Renuse S; Sahasrabuddhe NA; Prasad TS; Giri AK; Gowda H; Chatterjee A
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28000977
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.
Weinmuellner R; Kryeziu K; Zbiral B; Tav K; Schoenhacker-Alte B; Groza D; Wimmer L; Schosserer M; Nagelreiter F; Rösinger S; Mildner M; Tschachler E; Grusch M; Grillari J; Heffeter P
Arch Toxicol; 2018 Jan; 92(1):181-194. PubMed ID: 28776197
[TBL] [Abstract][Full Text] [Related]
20. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
